Solta Medical Fraxel re:pair SST
CO2 Fractional/Ablative · Fractional ablative CO2 10600nm
New Solta Medical Fraxel re:pair SST pricing is not published; used and refurbished systems trade around $15k–$30k. Solta Medical Fraxel re:pair SST holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: Fractional ablative CO2 resurfacing and coagulation of soft tissue
Last verified: August 6, 2026 · How we verify
New: —|Used: $15k–$30kmarket estimate, no email required
| Manufacturer | Solta Medical |
|---|---|
| Company | Owner: Bausch Health Companies Inc. (NYSE/TSX: BHC) (subsidiary, since 2014) · Distribution: direct |
| Category | Resurfacing, Tattoo & Vascular |
| Technology | Fractional ablative CO2 10600nm |
| FDA status | FDA Cleared |
| New price range | Not published |
| Used price range | $15k–$30k |
| Consumables | Not published |
| Launch year | 2008 |
| Last verified | August 6, 2026 |
Overview
Fraxel's ablative CO2 entry, no longer sold new
FDA & regulatory status
What it's actually cleared for:
Fractional ablative CO2 resurfacing and coagulation of soft tissue
510(k) numbers
K080915
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.